Comparison of Nocturnal Cough Analysis in Healthy Subjects and in Patients with Cystic Fibrosis and Primary Ciliary Dyskinesia: A Prospective Observational Study

Background: Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Objective: The study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. Methods: In this pros...

Full description

Saved in:
Bibliographic Details
Published inRespiration Vol. 97; no. 1; pp. 60 - 69
Main Authors Radine, Andrea, Werner, Claudius, Raidt, Johanna, Dougherty, Gerard W., Kerschke, Laura, Omran, Heymut, Grosse-Onnebrink, Joerg
Format Journal Article
LanguageEnglish
Published Basel, Switzerland 01.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Objective: The study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. Methods: In this prospective observational study, we used a microphone-based monitoring system (LEOSound® Monitor) to count the coughs in healthy subjects (HS) and in stable patients with CF and PCD (25 subjects per group) on 2 consecutive nights. Results: The median number of coughs/h in the HS, CF, and PCD groups was 0.0, 1.3, and 0.5 on the first night and 0.0, 2.3, and 0.2 on the second night, respectively. Patients with CF and PCD coughed more than HS (p < 0.001 and p = 0.009, respectively) and CF patients coughed more than PCD patients (p = 0.023). A multivariable mixed model analysis revealed forced expiratory volume in 1 s as an independent risk factor for increased cough frequency in patients. The reliability for repeated measurements was higher for cough epochs/h than for coughs/h (intraclass correlation coefficient: 0.75 and 0.49, respectively). Conclusions: Patients with CF cough more than patients with PCD. The cough frequency in CF and PCD is associated with parameters reflecting disease severity. Cough frequency is a possible endpoint in clinical trials and cough epochs/h may be more useful than coughs/h.
AbstractList Background: Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Objective: The study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. Methods: In this prospective observational study, we used a microphone-based monitoring system (LEOSound® Monitor) to count the coughs in healthy subjects (HS) and in stable patients with CF and PCD (25 subjects per group) on 2 consecutive nights. Results: The median number of coughs/h in the HS, CF, and PCD groups was 0.0, 1.3, and 0.5 on the first night and 0.0, 2.3, and 0.2 on the second night, respectively. Patients with CF and PCD coughed more than HS (p < 0.001 and p = 0.009, respectively) and CF patients coughed more than PCD patients (p = 0.023). A multivariable mixed model analysis revealed forced expiratory volume in 1 s as an independent risk factor for increased cough frequency in patients. The reliability for repeated measurements was higher for cough epochs/h than for coughs/h (intraclass correlation coefficient: 0.75 and 0.49, respectively). Conclusions: Patients with CF cough more than patients with PCD. The cough frequency in CF and PCD is associated with parameters reflecting disease severity. Cough frequency is a possible endpoint in clinical trials and cough epochs/h may be more useful than coughs/h.
Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). The study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. In this prospective observational study, we used a microphone-based monitoring system (LEOSound® Monitor) to count the coughs in healthy subjects (HS) and in stable patients with CF and PCD (25 subjects per group) on 2 consecutive nights. The median number of coughs/h in the HS, CF, and PCD groups was 0.0, 1.3, and 0.5 on the first night and 0.0, 2.3, and 0.2 on the second night, respectively. Patients with CF and PCD coughed more than HS (p < 0.001 and p = 0.009, respectively) and CF patients coughed more than PCD patients (p = 0.023). A multivariable mixed model analysis revealed forced expiratory volume in 1 s as an independent risk factor for increased cough frequency in patients. The reliability for repeated measurements was higher for cough epochs/h than for coughs/h (intraclass correlation coefficient: 0.75 and 0.49, respectively). Patients with CF cough more than patients with PCD. The cough frequency in CF and PCD is associated with parameters reflecting disease severity. Cough frequency is a possible endpoint in clinical trials and cough epochs/h may be more useful than coughs/h.
BACKGROUNDCough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). OBJECTIVEThe study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. METHODSIn this prospective observational study, we used a microphone-based monitoring system (LEOSound® Monitor) to count the coughs in healthy subjects (HS) and in stable patients with CF and PCD (25 subjects per group) on 2 consecutive nights. RESULTSThe median number of coughs/h in the HS, CF, and PCD groups was 0.0, 1.3, and 0.5 on the first night and 0.0, 2.3, and 0.2 on the second night, respectively. Patients with CF and PCD coughed more than HS (p < 0.001 and p = 0.009, respectively) and CF patients coughed more than PCD patients (p = 0.023). A multivariable mixed model analysis revealed forced expiratory volume in 1 s as an independent risk factor for increased cough frequency in patients. The reliability for repeated measurements was higher for cough epochs/h than for coughs/h (intraclass correlation coefficient: 0.75 and 0.49, respectively). CONCLUSIONSPatients with CF cough more than patients with PCD. The cough frequency in CF and PCD is associated with parameters reflecting disease severity. Cough frequency is a possible endpoint in clinical trials and cough epochs/h may be more useful than coughs/h.
Author Kerschke, Laura
Omran, Heymut
Raidt, Johanna
Radine, Andrea
Dougherty, Gerard W.
Grosse-Onnebrink, Joerg
Werner, Claudius
Author_xml – sequence: 1
  givenname: Andrea
  surname: Radine
  fullname: Radine, Andrea
– sequence: 2
  givenname: Claudius
  surname: Werner
  fullname: Werner, Claudius
– sequence: 3
  givenname: Johanna
  surname: Raidt
  fullname: Raidt, Johanna
– sequence: 4
  givenname: Gerard W.
  surname: Dougherty
  fullname: Dougherty, Gerard W.
– sequence: 5
  givenname: Laura
  surname: Kerschke
  fullname: Kerschke, Laura
– sequence: 6
  givenname: Heymut
  surname: Omran
  fullname: Omran, Heymut
– sequence: 7
  givenname: Joerg
  orcidid: 0000-0003-2053-4379
  surname: Grosse-Onnebrink
  fullname: Grosse-Onnebrink, Joerg
  email: joerg.grosse-onnebrink@ukmuenster.de
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30408808$$D View this record in MEDLINE/PubMed
BookMark eNptkctO3DAUhq2KqgzQRfcIWWJTFim-xLmwG6VQkFBBDF1HjnPCGDJ2sB1QHoc3JVHorFid23d-naN_D-0YawChH5T8olTkp4SQOOec8S9oQWPGI8JFsoMWhDARpTmnu2jP-0dCqMgy9g3tchKTLCPZAr0VdtNJp7012Db4r1Whd0a2uLD9wxovx3Tw2mNt8CXINqwHvOqrR1DBY2nqqX8rgwYz1q86rHEx-KAVvtCVs9PiBN06vZFuwIVu9RR_D_5JG_BanuHlOLW-GwX1C-CbyoN7GQXtdMMq9PVwgL42svXw_SPuo38X5_fFZXR98-eqWF5HivM4RKCSSjKeSgU1ECGSJm-kVISnIlc0ZbVKqEiTjEme17SOOVe5UtBQ0WQipxnfRz9n3c7Z5x58KDfaK2hbacD2vmSUM8YESyf0ZEbVeLp30JTd_GFJSTk5Um4dGdmjD9m-2kC9Jf9bMAKHM_Ak3QO4LbDdP_50fHe-momyqxv-Dr74n2E
CitedBy_id crossref_primary_10_1183_16000617_0354_2020
crossref_primary_10_1371_journal_pone_0262240
crossref_primary_10_1007_s00431_019_03426_4
crossref_primary_10_1002_ppul_25768
crossref_primary_10_1016_j_rmed_2023_107169
crossref_primary_10_1097_MCP_0000000000000968
crossref_primary_10_1002_ppul_25052
crossref_primary_10_1016_j_jcf_2024_02_011
crossref_primary_10_2147_JAA_S278119
crossref_primary_10_1007_s00431_022_04509_5
Cites_doi 10.1016/S0140-6736(16)00576-6
10.1136/adc.60.5.473
10.1002/ppul.10127
10.1002/ppul.20563
10.1378/chest.14-1481
10.1016/j.jcf.2011.02.003
10.1080/15412555.2017.1338681
10.1165/rcmb.2014-0250OC
10.1002/ppul.20202
10.1016/j.jcf.2010.12.004
10.1002/sim.4780090402
10.1016/j.rmed.2017.08.028
10.1016/j.jcf.2014.03.010
10.1016/j.jcf.2016.07.012
10.1002/ppul.10174
10.3389/fped.2017.00030
10.1002/ppul.22934
10.1159/000321231
10.1183/13993003.00776-2015
10.1016/j.ultramic.2005.04.007
10.1164/rccm.200811-1731OC
10.1378/chest.13-1162
10.2147/COPD.S154539
10.1038/nm.2715
10.1111/j.1469-8986.1966.tb02650.x
10.1183/09031936.00080312
10.1183/09031936.00176608
10.1186/2193-1801-3-40
10.1152/ajplung.00326.2014
10.1172/JCI73469
10.1136/thoraxjnl-2013-203204
10.1002/ppul.23217
10.1183/09031936.00101006
10.1136/thx.2005.050963
10.1002/ppul.21374
10.1016/j.jcf.2011.12.003
10.1016/j.prrv.2007.02.004
10.1378/chest.07-2812
10.1002/ppul.21004
10.1183/09031936.05.00034805
10.1186/1745-9974-1-3
10.1164/rccm.201301-0059CI
10.1002/ppul.22577
ContentType Journal Article
Copyright 2018 S. Karger AG, Basel
2018 S. Karger AG, Basel.
Copyright_xml – notice: 2018 S. Karger AG, Basel
– notice: 2018 S. Karger AG, Basel.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1159/000493323
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1423-0356
EndPage 69
ExternalDocumentID 10_1159_000493323
30408808
493323
Genre Journal Article
Comparative Study
Observational Study
GroupedDBID ---
.GJ
.XZ
0R~
0~5
0~B
123
29P
30W
327
34G
36B
39C
3O.
3V.
4.4
53G
5RE
7RQ
7RV
7X7
88E
8AO
8FI
8FJ
8G5
8UI
AAWTL
AAYIC
ABJNI
ABPAZ
ABUWG
ACGFS
ACPSR
ADAGL
ADBBV
AENEX
AEYAO
AFJJK
AFKRA
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
APPQY
AZPMC
AZQEC
BENPR
BKEYQ
BPHCQ
BVXVI
C45
CAG
CCPQU
COF
CS3
CYUIP
DU5
DWQXO
E0A
EBS
EJD
EMB
EMOBN
EX3
F5P
FB.
FYUFA
GNUQQ
GUQSH
HMCUK
HZ~
IAO
IHR
IHW
IY7
KUZGX
L7B
M1P
M2O
N9A
NAPCQ
O1H
O9-
OVD
PQQKQ
PROAC
PSQYO
RIG
RKO
RXVBD
SV3
TEORI
UJ6
UKHRP
WOW
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
ITC
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c334t-ec6ba237acede0556f9faac03759c172dc6157682a39d1d433c9ccef15f859183
ISSN 0025-7931
IngestDate Fri Oct 25 22:41:52 EDT 2024
Fri Dec 06 08:13:58 EST 2024
Sat Sep 28 08:27:38 EDT 2024
Thu Sep 05 17:57:50 EDT 2024
Thu Aug 29 12:04:38 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Cystic fibrosis
Cough frequency
Primary ciliary dyskinesia
Objective cough count
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
2018 S. Karger AG, Basel.
https://www.karger.com/Services/SiteLicenses
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c334t-ec6ba237acede0556f9faac03759c172dc6157682a39d1d433c9ccef15f859183
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0003-2053-4379
PMID 30408808
PQID 2132225278
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_2132225278
karger_primary_493323
crossref_primary_10_1159_000493323
pubmed_primary_30408808
PublicationCentury 2000
PublicationDate 2019-01-01
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
PublicationTitle Respiration
PublicationTitleAlternate Respiration
PublicationYear 2019
References Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, et al.. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol. 2007Mar;42(3):256–62. 10.1002/ppul.20563172457358755-6863
Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, Baktai G, et al.. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J. 2009Dec;34(6):1264–76. 10.1183/09031936.00176608199489090903-1936
Kerem E, Wilschanski M, Miller NL, Pugatsch T, Cohen T, Blau H, et al.. Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis. J Cyst Fibros. 2011May;10(3):193–200. 10.1016/j.jcf.2011.02.003214590511569-1993
Leconte S, Ferrant D, Dory V, Degryse J. Validated methods of cough assessment: a systematic review of the literature. Respiration. 2011;81(2):161–74. 10.1159/000321231210793811423-0356
Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, et al.; European Cystic Fibrosis Society. European Cystic Fibrosis S: European cystic fibrosis society standards of care: Best practice guidelines. J Cyst Fibros. 2014May;13Suppl 1:S23–42. 10.1016/j.jcf.2014.03.010248567751569-1993
Chinn S. The assessment of methods of measurement. Stat Med. 1990Apr;9(4):351–62. 10.1002/sim.478009040223629750277-6715
Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, et al.. Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia. Respir Med. 2017Oct;131:241–6. 10.1016/j.rmed.2017.08.028289470380954-6111
Archer LN, Simpson H. Night cough counts and diary card scores in asthma. Arch Dis Child. 1985May;60(5):473–4. 10.1136/adc.60.5.47340151540003-9888
Knowles MR, Daniels LA, Davis SD, Zariwala MA, Leigh MW. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Respir Crit Care Med. 2013Oct;188(8):913–22. 10.1164/rccm.201301-0059CI237961961073-449X
Kent BD, Lane SJ, van Beek EJ, Dodd JD, Costello RW, Tiddens HA. Asthma and cystic fibrosis: a tangled web. Pediatr Pulmonol. 2014Mar;49(3):205–13. 10.1002/ppul.22934244208178755-6863
Cameron AT. Essentials of count data regression. In: Baltagi B, editor. A companion to theoretical econometrics. 2001. pp. 331–48.
Collawn JF, Matalon S. CFTR and lung homeostasis. Am J Physiol Lung Cell Mol Physiol. 2014Dec;307(12):L917–23. 10.1152/ajplung.00326.2014253810271040-0605
Coyle MA, Keenan DB, Henderson LS, Watkins ML, Haumann BK, Mayleben DW, et al.. Evaluation of an ambulatory system for the quantification of cough frequency in patients with chronic obstructive pulmonary disease. Cough. 2005Aug;1(1):3. 10.1186/1745-9974-1-3162709231745-9974
Keiser NW, Birket SE, Evans IA, Tyler SR, Crooke AK, Sun X, et al.. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs. Am J Respir Cell Mol Biol. 2015Jun;52(6):683–94. 10.1165/rcmb.2014-0250OC253176691044-1549
Smith JA, Owen EC, Jones AM, Dodd ME, Webb AK, Woodcock A. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax. 2006May;61(5):425–9. 10.1136/thx.2005.050963164492660040-6376
Elborn JS. Cystic fibrosis. Lancet. 2016Nov;388(10059):2519–31. 10.1016/S0140-6736(16)00576-6271406700140-6736
Santamaria F, Montella S, Tiddens HA, Guidi G, Casotti V, Maglione M, et al.. Structural and functional lung disease in primary ciliary dyskinesia. Chest. 2008Aug;134(2):351–7. 10.1378/chest.07-2812184036630012-3692
Koehler U, Brandenburg U, Weissflog A, Sohrabi K, Groß V. [LEOSound, an innovative procedure for acoustic long-term monitoring of asthma symptoms (wheezing and coughing) in children and adults]. Pneumologie. 2014Apr;68(4):277–81.246156661438-8790
Bakker EM, van der Meijden JC, Nieuwhof EM, Hop WC, Tiddens HA. Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency. J Cyst Fibros. 2012May;11(3):223–30. 10.1016/j.jcf.2011.12.003222656031569-1993
Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications. Thorax. 2013Dec;68(12):1157–62. 10.1136/thoraxjnl-2013-203204237042280040-6376
Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012Dec;40(6):1324–43. 10.1183/09031936.00080312227436750903-1936
Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012Apr;18(4):509–19. 10.1038/nm.2715224814181078-8956
Hamutcu R, Francis J, Karakoc F, Bush A. Objective monitoring of cough in children with cystic fibrosis. Pediatr Pulmonol. 2002Nov;34(5):331–5. 10.1002/ppul.10174123574768755-6863
Cohen-Cymberknoh M, Simanovsky N, Hiller N, Hillel AG, Shoseyov D, Kerem E. Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency. Chest. 2014Apr;145(4):738–44. 10.1378/chest.13-1162240916060012-3692
Shah SA, Santago P, Rubin BK. Quantification of biopolymer filament structure. Ultramicroscopy. 2005Oct;104(3-4):244–54. 10.1016/j.ultramic.2005.04.007159612310304-3991
Fischer P, Gross V, Kroenig J, Weissflog A, Hildebrandt O, Sohrabi K, et al.. Description of nighttime cough epochs in patients with stable COPD GOLD II-IV. Int J Chron Obstruct Pulmon Dis. 2018Apr;13:1071–8. 10.2147/COPD.S154539296623091176-9106
Goutaki M, Halbeisen FS, Spycher BD, Maurer E, Belle F, Amirav I, et al.. Swiss PCDG, French Reference Centre for Rare Lung D: Growth and nutritional status, and their association with lung function: A study from the international primary ciliary dyskinesia cohort. Eur Respir J. 2017;•••:50.0903-1936
Krönig J, Hildebrandt O, Weissflog A, Cassel W, Gross V, Sohrabi K, et al.. Long-term recording of night-time respiratory symptoms in patients with stable copd ii-iv. COPD. 2017Oct;14(5):498–503. 10.1080/15412555.2017.1338681287152321541-2555
Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, et al.; EPIC Study Group. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. Pediatr Pulmonol. 2015Aug;50(8):763–70. 10.1002/ppul.23217260619148755-6863
Aly SS, Zhao J, Li B, Jiang J. Reliability of environmental sampling culture results using the negative binomial intraclass correlation coefficient. Springerplus. 2014Jan;3(1):40. 10.1186/2193-1801-3-40245167832193-1801
von Heydebrand M, Hildebrandt O, Cassel W, Schäfer A, Kesper K, Weissflog A, et al.. [Apnea Detection by Means of Respiratory Sound Recordings and Polysomnography - A Comparative Study]. Pneumologie. 2017Sep;71(9):594–9.287599341438-8790
Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002Aug;34(2):91–100. 10.1002/ppul.10127121127748755-6863
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005Aug;26(2):319–38. 10.1183/09031936.05.00034805160558820903-1936
Proesmans M, Els C, Vermeulen F, De Boeck K. Change in IgG and evolution of lung function in children with cystic fibrosis. J Cyst Fibros. 2011Mar;10(2):128–31. 10.1016/j.jcf.2010.12.004212202151569-1993
Canning BJ, Chang AB, Bolser DC, Smith JA, Mazzone SB, McGarvey L, et al.; CHEST Expert Cough Panel. Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report. Chest. 2014Dec;146(6):1633–48. 10.1378/chest.14-1481251885300012-3692
Agnew HWJr, WebbWB, Williams RL. The first night effect: an EEG study of sleep. Psychophysiology. 1966Jan;2(3):263–6. 10.1111/j.1469-8986.1966.tb02650.x59035790048-5772
Werner C, Lablans M, Ataian M, Raidt J, Wallmeier J, Große-Onnebrink J, et al.. An international registry for primary ciliary dyskinesia. Eur Respir J. 2016Mar;47(3):849–59. 10.1183/13993003.00776-2015266591070903-1936
Henderson AG, Ehre C, Button B, Abdullah LH, Cai LH, Leigh MW, et al.. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest. 2014Jul;124(7):3047–60. 10.1172/JCI73469248928080021-9738
Gillissen A, Richter A, Oster H: Clinical efficacy of short-term treatment with extra-fine hfa beclomethasone dipropionate in patients with post-infectious persistent cough. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2007;58 Suppl 5:223-232.
Redding GJ, Carter ER. Chronic suppurative lung disease in children: definition and spectrum of disease. Front Pediatr. 2017Feb;5:30. 10.3389/fped.2017.00030282896732296-2360
Keating C, Poor AD, Liu X, Chiuzan C, Backenroth D, Zhang Y, et al.. Reduced survival in adult cystic fibrosis despite attenuated lung function decline. J Cyst Fibros. 2017Jan;16(1):78–84. 10.1016/j.jcf.2016.07.012275223111569-1993
Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, et al.; European Respiratory Society (ERS). ERS guidelines on the assessment of cough. Eur Respir J. 2007Jun;29(6):1256–76. 10.1183/09031936.00101006175407880903-1936
Sanders DB, Bittner RC, Rosenfeld M, Redding GJ, Goss CH. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011Apr;46(4):393–400. 10.1002/ppul.21374209678458755-6863
van der Giessen L, Loeve M, de Jongste J, Hop W, Tiddens H. Nocturnal cough in children with stable cystic fibrosis. Pediatr Pulmonol. 2009Sep;44(9):859–65. 10.1002/ppul.21004196704028755-6863
Rubin BK. Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev. 2007Mar;8(1):4–7. 10.1016/j.prrv.2007.02.004174199721526-0542
Marthin JK, Petersen N, Skovgaard LT, Nielsen KG. Lung function
ref13
ref35
ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref39
ref16
ref38
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref42
ref41
ref22
ref21
ref43
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref40
References_xml – ident: ref33
  doi: 10.1016/S0140-6736(16)00576-6
– ident: ref3
  doi: 10.1136/adc.60.5.473
– ident: ref19
  doi: 10.1002/ppul.10127
– ident: ref18
  doi: 10.1002/ppul.20563
– ident: ref27
  doi: 10.1378/chest.14-1481
– ident: ref25
  doi: 10.1016/j.jcf.2011.02.003
– ident: ref9
  doi: 10.1080/15412555.2017.1338681
– ident: ref30
  doi: 10.1165/rcmb.2014-0250OC
– ident: ref12
  doi: 10.1002/ppul.20202
– ident: ref17
  doi: 10.1016/j.jcf.2010.12.004
– ident: ref22
  doi: 10.1002/sim.4780090402
– ident: ref16
  doi: 10.1016/j.rmed.2017.08.028
– ident: ref5
  doi: 10.1016/j.jcf.2014.03.010
– ident: ref41
  doi: 10.1016/j.jcf.2016.07.012
– ident: ref2
  doi: 10.1002/ppul.10174
– ident: ref28
  doi: 10.3389/fped.2017.00030
– ident: ref43
  doi: 10.1002/ppul.22934
– ident: ref4
  doi: 10.1159/000321231
– ident: ref7
  doi: 10.1183/13993003.00776-2015
– ident: ref35
  doi: 10.1016/j.ultramic.2005.04.007
– ident: ref39
  doi: 10.1164/rccm.200811-1731OC
– ident: ref29
  doi: 10.1378/chest.13-1162
– ident: ref8
  doi: 10.2147/COPD.S154539
– ident: ref37
  doi: 10.1038/nm.2715
– ident: ref13
  doi: 10.1111/j.1469-8986.1966.tb02650.x
– ident: ref15
  doi: 10.1183/09031936.00080312
– ident: ref6
  doi: 10.1183/09031936.00176608
– ident: ref23
  doi: 10.1186/2193-1801-3-40
– ident: ref31
  doi: 10.1152/ajplung.00326.2014
– ident: ref32
  doi: 10.1172/JCI73469
– ident: ref36
  doi: 10.1136/thoraxjnl-2013-203204
– ident: ref21
  doi: 10.1002/ppul.23217
– ident: ref10
  doi: 10.1183/09031936.00101006
– ident: ref11
  doi: 10.1136/thx.2005.050963
– ident: ref20
  doi: 10.1002/ppul.21374
– ident: ref24
  doi: 10.1016/j.jcf.2011.12.003
– ident: ref34
  doi: 10.1016/j.prrv.2007.02.004
– ident: ref42
  doi: 10.1378/chest.07-2812
– ident: ref1
  doi: 10.1002/ppul.21004
– ident: ref14
  doi: 10.1183/09031936.05.00034805
– ident: ref26
  doi: 10.1186/1745-9974-1-3
– ident: ref38
  doi: 10.1164/rccm.201301-0059CI
– ident: ref40
  doi: 10.1002/ppul.22577
SSID ssj0015882
Score 2.3190305
Snippet Background: Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Objective: The study objectives were to test...
Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). The study objectives were to test whether cough is related...
BACKGROUNDCough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). OBJECTIVEThe study objectives were to test whether...
SourceID proquest
crossref
pubmed
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 60
SubjectTerms Adolescent
Adult
Child
Ciliary Motility Disorders - complications
Ciliary Motility Disorders - diagnosis
Circadian Rhythm - physiology
Clinical Investigations
Cough - diagnosis
Cough - etiology
Cystic Fibrosis - complications
Cystic Fibrosis - diagnosis
Female
Follow-Up Studies
Forced Expiratory Volume - physiology
Healthy Volunteers
Humans
Male
Middle Aged
Monitoring, Physiologic - methods
Prospective Studies
Respiratory Function Tests
Severity of Illness Index
Young Adult
Title Comparison of Nocturnal Cough Analysis in Healthy Subjects and in Patients with Cystic Fibrosis and Primary Ciliary Dyskinesia: A Prospective Observational Study
URI https://karger.com/doi/10.1159/000493323
https://www.ncbi.nlm.nih.gov/pubmed/30408808
https://search.proquest.com/docview/2132225278
Volume 97
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELe6Dk17QfwZUBiTQfBUZWtju0l4K2HThESZpk3sLXIcR4SNpOrah_Ft-CZ8NHz-lxSYBLyklZvESu7Xu7Pv7ncIvSpDGoMlD8Y0jwPKJVDeslFQyIhPch5PIsP2OZscn9P3F-yi1_vRyVpaLfN98e2PdSX_I1U1puQKVbL_IFl_UzWgviv5qqOSsDr-lYzTbhPB4ayBcECtdwOg9Y7nG9F0VpDmpfXEF52_YUiXgKG_amvc0htgbR4eqSV0AxeaSgJDR5FWVxV8vru5voRU-YqbovaTReOqNYcfc7_HCyQjnrnWEYDbsH4n9H8KKfzSZ1a2NkIubCVOesVXRbVqU_J5VSxtEjGva38FrAQ-A1Gw2elfAItkGr6ejj7td3c2oJjK72y4SgOg07RWQhoFrdy_YEQMGbnT4CbDdw2pRh2bVgXWsJuWML-bDJaYHEuaEGJqnzvQmX_V2CFK1ylNF7dW0-cymss20CZQMdI-2nx7ODs59ZEsFsehbxusnsWyW6lZD_yc22jLTbDmHt25hGqAxe2LH-0End1Dd-3qBU8NFO-jnqwfoK0PNj_jIfreIhI3JfaIxBqR2CESVzW2iMQOkViBDcYdIjEgEhtEYodIfZJFJLaIxC0i3-Ap7uARr-ERazzuoPOjw7P0OLBNQAJBCF0GUiiVEZKIC1lIYH4qk5JzAa2bE6G870Ion1ytmUNOkmJcUEJEIoQsx6wEasaYPEL9uqnlE4RZmEeTSU4oK8Y0ZlGeiILSmMcsh1fPB-ile_fZ3DxKptfILMm8rAZox0jFn-LGd38ZVxrU_JTNi3KAXjgZZkqBQ1SO17JZXWehDnayMIoH6LERrr-FQ8XTWyZ9hrbbP84u6i8XK_lcOcnLfA9tRBfRnkXjT6XTv1w
link.rule.ids 314,780,784,27924,27925,31720,33745
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+Nocturnal+Cough+Analysis+in+Healthy+Subjects+and+in+Patients+with+Cystic+Fibrosis+and+Primary+Ciliary+Dyskinesia%3A+A+Prospective+Observational+Study&rft.jtitle=Respiration&rft.au=Radine%2C+Andrea&rft.au=Werner%2C+Claudius&rft.au=Raidt%2C+Johanna&rft.au=Dougherty%2C+Gerard%C2%A0W.&rft.date=2019-01-01&rft.issn=0025-7931&rft.eissn=1423-0356&rft.volume=97&rft.issue=1&rft.spage=60&rft.epage=69&rft_id=info:doi/10.1159%2F000493323&rft_id=info%3Apmid%2F30408808&rft.externalDocID=493323
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7931&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7931&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7931&client=summon